US Stock MarketDetailed Quotes

AMRX Amneal Pharmaceuticals

Watchlist
  • 7.440
  • +0.060+0.81%
Close Jul 26 16:00 ET
  • 7.440
  • 0.0000.00%
Post 20:01 ET
2.30BMarket Cap-10191P/E (TTM)

Amneal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-103.16%-4.41M
430.84%345.58M
683.13%135.82M
-13.02%81.39M
90.96%-11.35M
16.09%139.71M
-73.08%65.1M
-136.82%-23.29M
13.61%93.57M
-141.70%-125.52M
Net income from continuing operations
-709.17%-81.68M
80.88%-48.72M
-1,493.44%-93.34M
1,147.41%25.03M
112.36%29.68M
-56.25%-10.09M
-1,363.21%-254.79M
71.37%-5.86M
60.77%-2.39M
-846.15%-240.08M
Operating gains losses
176.04%1.51M
-105.06%-768K
-216.20%-2.33M
-35.97%3.12M
-91.75%426K
-163.28%-1.99M
8,580.00%15.19M
645.72%2.01M
2,338.07%4.88M
146.66%5.17M
Depreciation and amortization
-4.51%55.53M
-4.49%229.4M
-6.75%56.93M
-7.15%57.21M
-4.33%57.11M
0.58%58.15M
2.90%240.18M
-0.21%61.06M
2.36%61.61M
5.68%59.7M
Other non cash items
-75.04%1.64M
154.59%44.41M
401.19%31.95M
97.19%8.49M
-180.26%-2.58M
84.85%6.56M
14.86%17.45M
678.40%6.37M
-52.46%4.3M
-11.21%3.22M
Change In working capital
-122.06%-11.97M
21.28%-47.19M
139.72%53.7M
-712.66%-34.74M
-735.91%-120.43M
7.16%54.28M
55.13%-59.95M
-521.76%-135.21M
331.81%5.67M
111.52%18.94M
-Change in receivables
-128.37%-55.74M
259.10%125.8M
169.45%77.88M
-132.46%-19.4M
14.49%-129.11M
58.07%196.44M
-384.80%-79.07M
-225.89%-112.12M
150.32%59.77M
-31.91%-150.99M
-Change in inventory
45.80%-12.2M
-23.23%-126.18M
-108.58%-23.09M
-64.15%-42.57M
4.59%-38.02M
11.90%-22.51M
-108.91%-102.4M
-166.57%-11.07M
-134.39%-25.93M
-16.18%-39.85M
-Change in prepaid assets
-140.15%-11.71M
282.66%37.81M
-70.62%13M
-108.30%-7.09M
102.37%2.74M
759.28%29.16M
144.96%9.88M
703.01%44.26M
2,535.58%85.37M
-368.99%-115.32M
-Change in payables and accrued expense
145.47%67.67M
-175.79%-84.62M
74.96%-14.09M
130.23%34.32M
-86.48%43.96M
-240.96%-148.81M
341.19%111.64M
-493.57%-56.28M
-865.71%-113.54M
3,545.85%325.1M
Cash from discontinued investing activities
Operating cash flow
-103.16%-4.41M
430.84%345.58M
683.13%135.82M
-13.02%81.39M
90.96%-11.35M
16.09%139.71M
-73.08%65.1M
-136.82%-23.29M
13.61%93.57M
-141.70%-125.52M
Investing cash flow
Cash flow from continuing investing activities
-68.36%-19.76M
60.31%-69.19M
-176.40%-31.69M
72.68%-13.48M
23.78%-12.28M
87.95%-11.74M
10.23%-174.31M
86.82%-11.47M
-324.07%-49.33M
80.56%-16.12M
Net PPE purchase and sale
11.75%-10.06M
4.09%-46.8M
-2.84%-11.79M
28.84%-12.48M
-56.46%-11.13M
10.11%-11.4M
4.21%-48.8M
36.49%-11.47M
-50.71%-17.53M
16.86%-7.12M
Net intangibles purchase and sale
-2,769.82%-9.7M
46.44%-22.39M
---19.9M
96.86%-1M
88.50%-1.15M
---338K
-2,358.82%-41.8M
--0
---31.8M
---10M
Net business purchase and sale
----
--0
--0
--0
----
----
42.19%-84.71M
--0
--0
--0
Net other investing changes
----
----
----
----
----
----
-80.00%1M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
-68.36%-19.76M
60.31%-69.19M
-176.40%-31.69M
72.68%-13.48M
23.78%-12.28M
87.95%-11.74M
10.23%-174.31M
86.82%-11.47M
-324.07%-49.33M
80.56%-16.12M
Financing cash flow
Cash flow from continuing financing activities
-79.50%-23.16M
-99.37%-212.57M
-354.87%-100.83M
-87.69%-86.59M
-152.72%-12.26M
79.05%-12.9M
22.81%-106.62M
26.96%-22.17M
-5.92%-46.13M
161.07%23.25M
Net issuance payments of debt
-309.47%-15.38M
159.19%22.65M
463.44%64.16M
-26.61%-53.94M
-83.98%5.09M
174.94%7.34M
51.66%-38.27M
77.39%-17.65M
-225.78%-42.61M
410.23%31.79M
Proceeds from stock option exercised by employees
--28K
-31.87%451K
--43K
-3.55%408K
--0
--0
-22.39%662K
--0
176.47%423K
2,460.00%128K
Net other financing activities
61.43%-7.81M
-241.51%-235.68M
-3,556.92%-165.04M
-737.32%-33.05M
-100.22%-17.35M
60.99%-20.24M
-15.41%-69.01M
-109.46%-4.51M
94.91%-3.95M
68.86%-8.67M
Cash from discontinued financing activities
Financing cash flow
-79.50%-23.16M
-99.37%-212.57M
-354.87%-100.83M
-87.69%-86.59M
-152.72%-12.26M
79.05%-12.9M
22.81%-106.62M
26.96%-22.17M
-5.92%-46.13M
161.07%23.25M
Net cash flow
Beginning cash position
181.34%99.11M
-86.28%35.23M
-0.30%95.61M
16.70%114.58M
-30.24%151.07M
-86.28%35.23M
-26.04%256.74M
-69.13%95.89M
-65.33%98.18M
-52.49%216.55M
Current changes in cash
-141.13%-47.33M
129.57%63.82M
105.80%3.3M
-885.96%-18.67M
69.69%-35.89M
397.95%115.08M
-138.53%-215.83M
-5.30%-56.93M
-106.97%-1.89M
31.52%-118.39M
Effect of exchange rate changes
-121.51%-165K
101.14%65K
105.38%201K
24.18%-301K
-2,508.00%-602K
148.79%767K
-5,671.57%-5.68M
-2,200.56%-3.74M
-236.90%-397K
-88.99%25K
End cash Position
-65.83%51.62M
181.34%99.11M
181.34%99.11M
-0.30%95.61M
16.70%114.58M
-30.24%151.07M
-86.28%35.23M
-86.28%35.23M
-69.13%95.89M
-65.33%98.18M
Free cash flow
-118.89%-24.17M
1,184.09%276.39M
399.59%104.13M
53.51%67.91M
83.43%-23.63M
18.87%127.98M
-113.48%-25.5M
-178.98%-34.76M
-37.46%44.24M
-133.86%-142.64M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -103.16%-4.41M430.84%345.58M683.13%135.82M-13.02%81.39M90.96%-11.35M16.09%139.71M-73.08%65.1M-136.82%-23.29M13.61%93.57M-141.70%-125.52M
Net income from continuing operations -709.17%-81.68M80.88%-48.72M-1,493.44%-93.34M1,147.41%25.03M112.36%29.68M-56.25%-10.09M-1,363.21%-254.79M71.37%-5.86M60.77%-2.39M-846.15%-240.08M
Operating gains losses 176.04%1.51M-105.06%-768K-216.20%-2.33M-35.97%3.12M-91.75%426K-163.28%-1.99M8,580.00%15.19M645.72%2.01M2,338.07%4.88M146.66%5.17M
Depreciation and amortization -4.51%55.53M-4.49%229.4M-6.75%56.93M-7.15%57.21M-4.33%57.11M0.58%58.15M2.90%240.18M-0.21%61.06M2.36%61.61M5.68%59.7M
Other non cash items -75.04%1.64M154.59%44.41M401.19%31.95M97.19%8.49M-180.26%-2.58M84.85%6.56M14.86%17.45M678.40%6.37M-52.46%4.3M-11.21%3.22M
Change In working capital -122.06%-11.97M21.28%-47.19M139.72%53.7M-712.66%-34.74M-735.91%-120.43M7.16%54.28M55.13%-59.95M-521.76%-135.21M331.81%5.67M111.52%18.94M
-Change in receivables -128.37%-55.74M259.10%125.8M169.45%77.88M-132.46%-19.4M14.49%-129.11M58.07%196.44M-384.80%-79.07M-225.89%-112.12M150.32%59.77M-31.91%-150.99M
-Change in inventory 45.80%-12.2M-23.23%-126.18M-108.58%-23.09M-64.15%-42.57M4.59%-38.02M11.90%-22.51M-108.91%-102.4M-166.57%-11.07M-134.39%-25.93M-16.18%-39.85M
-Change in prepaid assets -140.15%-11.71M282.66%37.81M-70.62%13M-108.30%-7.09M102.37%2.74M759.28%29.16M144.96%9.88M703.01%44.26M2,535.58%85.37M-368.99%-115.32M
-Change in payables and accrued expense 145.47%67.67M-175.79%-84.62M74.96%-14.09M130.23%34.32M-86.48%43.96M-240.96%-148.81M341.19%111.64M-493.57%-56.28M-865.71%-113.54M3,545.85%325.1M
Cash from discontinued investing activities
Operating cash flow -103.16%-4.41M430.84%345.58M683.13%135.82M-13.02%81.39M90.96%-11.35M16.09%139.71M-73.08%65.1M-136.82%-23.29M13.61%93.57M-141.70%-125.52M
Investing cash flow
Cash flow from continuing investing activities -68.36%-19.76M60.31%-69.19M-176.40%-31.69M72.68%-13.48M23.78%-12.28M87.95%-11.74M10.23%-174.31M86.82%-11.47M-324.07%-49.33M80.56%-16.12M
Net PPE purchase and sale 11.75%-10.06M4.09%-46.8M-2.84%-11.79M28.84%-12.48M-56.46%-11.13M10.11%-11.4M4.21%-48.8M36.49%-11.47M-50.71%-17.53M16.86%-7.12M
Net intangibles purchase and sale -2,769.82%-9.7M46.44%-22.39M---19.9M96.86%-1M88.50%-1.15M---338K-2,358.82%-41.8M--0---31.8M---10M
Net business purchase and sale ------0--0--0--------42.19%-84.71M--0--0--0
Net other investing changes -------------------------80.00%1M--0--0----
Cash from discontinued investing activities
Investing cash flow -68.36%-19.76M60.31%-69.19M-176.40%-31.69M72.68%-13.48M23.78%-12.28M87.95%-11.74M10.23%-174.31M86.82%-11.47M-324.07%-49.33M80.56%-16.12M
Financing cash flow
Cash flow from continuing financing activities -79.50%-23.16M-99.37%-212.57M-354.87%-100.83M-87.69%-86.59M-152.72%-12.26M79.05%-12.9M22.81%-106.62M26.96%-22.17M-5.92%-46.13M161.07%23.25M
Net issuance payments of debt -309.47%-15.38M159.19%22.65M463.44%64.16M-26.61%-53.94M-83.98%5.09M174.94%7.34M51.66%-38.27M77.39%-17.65M-225.78%-42.61M410.23%31.79M
Proceeds from stock option exercised by employees --28K-31.87%451K--43K-3.55%408K--0--0-22.39%662K--0176.47%423K2,460.00%128K
Net other financing activities 61.43%-7.81M-241.51%-235.68M-3,556.92%-165.04M-737.32%-33.05M-100.22%-17.35M60.99%-20.24M-15.41%-69.01M-109.46%-4.51M94.91%-3.95M68.86%-8.67M
Cash from discontinued financing activities
Financing cash flow -79.50%-23.16M-99.37%-212.57M-354.87%-100.83M-87.69%-86.59M-152.72%-12.26M79.05%-12.9M22.81%-106.62M26.96%-22.17M-5.92%-46.13M161.07%23.25M
Net cash flow
Beginning cash position 181.34%99.11M-86.28%35.23M-0.30%95.61M16.70%114.58M-30.24%151.07M-86.28%35.23M-26.04%256.74M-69.13%95.89M-65.33%98.18M-52.49%216.55M
Current changes in cash -141.13%-47.33M129.57%63.82M105.80%3.3M-885.96%-18.67M69.69%-35.89M397.95%115.08M-138.53%-215.83M-5.30%-56.93M-106.97%-1.89M31.52%-118.39M
Effect of exchange rate changes -121.51%-165K101.14%65K105.38%201K24.18%-301K-2,508.00%-602K148.79%767K-5,671.57%-5.68M-2,200.56%-3.74M-236.90%-397K-88.99%25K
End cash Position -65.83%51.62M181.34%99.11M181.34%99.11M-0.30%95.61M16.70%114.58M-30.24%151.07M-86.28%35.23M-86.28%35.23M-69.13%95.89M-65.33%98.18M
Free cash flow -118.89%-24.17M1,184.09%276.39M399.59%104.13M53.51%67.91M83.43%-23.63M18.87%127.98M-113.48%-25.5M-178.98%-34.76M-37.46%44.24M-133.86%-142.64M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg